Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease

What can we do to Prevent Infections in Adult Patients with Rheumatic Diseases?

“…Lanternier et al reported a low influenzavaccination rate (28%) among patients with systemic inflammatory disease. In this report, age >65 years was significantly associated with influenza vaccination (46%), but lower than that in the general population of the same age (70%) [23]. Forty-nine per cent of patients who remembered having received a letter from the National Health Insurance Service encouraging them to have the vaccine were vaccinated compared with 18% who did not remember (p<0.001).…”

How to reduce morbidity and mortality from chest infections in rheumatoid arthritis

“…13,14 However, low rates have also been reported. 15,16 Although awareness of the importance of vaccination for RA patients has grown the potential for certain drugs, such as steroids, MTX and anti-TNF therapy, to reduce the efficacy of the vaccination programme has also been recognised. 17 This underlines the potential value of vaccination early in the disease, although further research on the effect of drugs such as MTX on pneumococcal antibody levels in RA patients are needed to inform the development of optimal vaccination schedules.…”

Assessment of the Immunogenicity and Safety of 23-Valent Polysaccharide Pneumococcal Vaccine in Patients With Rheumatic Diseases

“…Такая позиция, ве-роятно, обусловлена неверной и недостаточной информи-рованностью последних в отношении эффективности и безопасности иммунизации, что является одной из причин низкого охвата вакцинацией больных ревматологического профиля [8][9][10].…”